Your browser doesn't support javascript.
loading
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review.
Cao, Qiang; Wu, Xinyan; Zhang, Qi; Gong, Junling; Chen, Yuquan; You, Yanwei; Shen, Jun; Qiang, Yi; Cao, Guangzhu.
Afiliación
  • Cao Q; Department of Earth Sciences, Kunming University of Science and Technology, Kunming, China.
  • Wu X; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Zhang Q; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China.
  • Gong J; Undergraduate Department, Taishan University, Taian, China.
  • Chen Y; School of Public Health, Nanchang University, Nanchang, China.
  • You Y; Institute of Medical Information/Library, Chinese Academy of Medical Sciences, Beijing, China.
  • Shen J; Division of Sports Science & Physical Education, Tsinghua University, Beijing, China.
  • Qiang Y; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Cao G; Department of Earth Sciences, Kunming University of Science and Technology, Kunming, China.
Front Pharmacol ; 14: 1291920, 2023.
Article en En | MEDLINE | ID: mdl-38026941

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza